Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series

Inhaled Antibiotics for Refractory Nontuberculous Mycobacteria and Non–Cystic Fibrosis Bronchiectasis and the Significance ofMycobacterium abscessussubsp.abscessusIsolation duringM. aviumComplex Lung Disease Therapy

(2015) Vikramjit Mukherjee et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Carbapenems and Rifampin Exhibit Synergy against Mycobacterium tuberculosis and Mycobacterium abscessus

(2015) Amit Kaushik et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan

(2013) Chien-Wen Huang et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Discrimination of Mycobacterium abscessus subsp. massiliense from Mycobacterium abscessus subsp. abscessus in Clinical Isolates by Multiplex PCR

(2013) K. Nakanaga et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Macrolide Treatment forMycobacterium abscessusandMycobacterium massilienseInfection and Inducible Resistance

(2012) Go-Eun Choi et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

In VitroSynergy between Clofazimine and Amikacin in Treatment of Nontuberculous Mycobacterial Disease

(2012) Jakko van Ingen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical and Microbiological Differences between Mycobacterium abscessus and Mycobacterium massiliense Lung Diseases

(2012) T. Harada et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Clinical and Microbiologic Outcomes in Patients Receiving Treatment for Mycobacterium abscessus Pulmonary Disease

(2011) Julie Jarand et al.   CLINICAL INFECTIOUS DISEASES

Aerosolized amikacin in patients with difficult-to-treat pulmonary nontuberculous mycobacteriosis

(2011) A. Safdar   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Comparative in vitro and in vivo antimicrobial activities of sitafloxacin, gatifloxacin and moxifloxacin against Mycobacterium avium

(2011) Chiaki Sano et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Outcomes in patients with Mycobacterium abscessus pulmonary disease treated with long-term injectable drugs

(2011) Jiwon Lyu et al.   RESPIRATORY MEDICINE

Nontuberculous Mycobacterial Lung Disease Prevalence at Four Integrated Health Care Delivery Systems

(2010) D. Rebecca Prevots et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Increasing reports of non-tuberculous mycobacteria in England, Wales and Northern Ireland, 1995-2006

(2010) Jonathan E Moore et al.   BMC PUBLIC HEALTH

High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria

(2010) Gwan-Han Shen et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Clinical Outcome of Mycobacterium abscessus Infection and Antimicrobial Susceptibility Testing

(2010) Yi-Ching Huang et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Antibiotic susceptibility pattern of rapidly growing mycobacteria

(2010) LilyK Therese et al.   Journal of Postgraduate Medicine

In Vitro Antimicrobial Susceptibility of Mycobacterium abscessus in Korea

(2008) Sunghoon Park et al.   JOURNAL OF KOREAN MEDICAL SCIENCE